Day: April 11, 2018

Neuralstem to Present Clinical Update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day

GERMANTOWN, Md., April 11, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, Chief Scientific Officer of Neuralstem, will be providing a clinical update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day at the Metropolitan Club […]

Posted in Uncategorized

OmniComm Systems Signs First TrialMaster® Customer in China

Shanghai HEP Pharma Selects TrialMaster EDC to Conduct Hepatitis B Study FORT LAUDERDALE, Fla., April 10, 2018 (GLOBE NEWSWIRE) — Shanghai HEP Pharma Co. LTD, a research and development company focused on developing innovative drugs for hepatitis B, has signed a new agreement with OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data […]

Posted in Uncategorized

Tier1CRM Welcomes Doug Christensen as its First Vice President of Strategy

Capital Markets Industry Veteran to Strengthen and Expand Management Team TORONTO and NEW YORK, April 10, 2018 (GLOBE NEWSWIRE) — Tier1CRM (“Tier1”), a leading provider of cloud-based customer relationship management (“CRM”) solutions for the capital markets industry, announced today the addition of Doug Christensen as the Company’s first Vice President of Strategy. Doug brings more […]